Skip to content

Integra LifeSciences IART Market capitalization

Market capitalization at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$44.73B-32.0%
Stryker logo
StrykerSYK
$125.84B-11.4%
Axogen logo
AxogenAXGN
$1.72B+110%
Globus Medical logo
Globus MedicalGMED
$11.65B+15.7%
AbbVie logo
AbbVieABBV
$384.69B+3.8%
Medtronic logo
MedtronicMDT
$103.96B-3.8%

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Enterprise value$3.12B-26.7%
P/S0.8×-1.1×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Computed from the period-end share price: $734.17M.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's market capitalization?
Integra LifeSciences (IART) reported market capitalization of $734.17M in Q1 2026.
How has Integra LifeSciences's market capitalization changed year-over-year?
Integra LifeSciences's market capitalization decreased by 56.8% year-over-year, from $1.7B to $734.17M.
What is the long-term trend for Integra LifeSciences's market capitalization?
Over 5 years (2020 to 2025), Integra LifeSciences's market capitalization has grown at a -29.4% compound annual growth rate (CAGR), from $5.5B to $967.42M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.